BR112018074478A2 - peptídeo antimicrobiano modificado derivado de um domínio rico em arginina - Google Patents
peptídeo antimicrobiano modificado derivado de um domínio rico em argininaInfo
- Publication number
- BR112018074478A2 BR112018074478A2 BR112018074478-6A BR112018074478A BR112018074478A2 BR 112018074478 A2 BR112018074478 A2 BR 112018074478A2 BR 112018074478 A BR112018074478 A BR 112018074478A BR 112018074478 A2 BR112018074478 A2 BR 112018074478A2
- Authority
- BR
- Brazil
- Prior art keywords
- antimicrobial peptide
- peptide derived
- rich domain
- arginine rich
- modified antimicrobial
- Prior art date
Links
- 108700042778 Antimicrobial Peptides Proteins 0.000 title abstract 2
- 102000044503 Antimicrobial Peptides Human genes 0.000 title abstract 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 title abstract 2
- 239000004475 Arginine Substances 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/40—Viruses, e.g. bacteriophages
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10031—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10133—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662342415P | 2016-05-27 | 2016-05-27 | |
| US62/342,415 | 2016-05-27 | ||
| PCT/US2017/034489 WO2017205631A1 (en) | 2016-05-27 | 2017-05-25 | Modified antimicrobial peptide derived from an arginine-rich domain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018074478A2 true BR112018074478A2 (pt) | 2019-03-19 |
Family
ID=60411947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018074478-6A BR112018074478A2 (pt) | 2016-05-27 | 2017-05-25 | peptídeo antimicrobiano modificado derivado de um domínio rico em arginina |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20190144510A1 (enExample) |
| EP (1) | EP3464329A4 (enExample) |
| JP (1) | JP7161263B6 (enExample) |
| KR (1) | KR102530478B1 (enExample) |
| CN (1) | CN109641938A (enExample) |
| AU (1) | AU2017270201A1 (enExample) |
| BR (1) | BR112018074478A2 (enExample) |
| CA (1) | CA3024873A1 (enExample) |
| IL (1) | IL263086A (enExample) |
| MX (1) | MX2018014490A (enExample) |
| SG (1) | SG11201809928VA (enExample) |
| TW (1) | TWI635095B (enExample) |
| WO (1) | WO2017205631A1 (enExample) |
| ZA (1) | ZA201807763B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202317598A (zh) * | 2021-09-01 | 2023-05-01 | 美商艾姆麥克斯治療股份有限公司 | 具有抗微生物活性的胜肽 |
| KR102544102B1 (ko) * | 2021-11-05 | 2023-06-19 | 주식회사 레메디 | 상처 치료 및 항염증 활성을 가지는 펩타이드 및 이의 용도 |
| US11713341B1 (en) | 2022-06-17 | 2023-08-01 | Vestaron Corporation | Antimicrobial NCR13 variant peptides |
| CN116947974B (zh) * | 2023-07-25 | 2025-03-11 | 武汉大学人民医院（湖北省人民医院） | 一种来源于中药美洲大蠊的多聚精氨酸修饰肽及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001500012A (ja) * | 1996-09-03 | 2001-01-09 | ザ ジェネラル ホスピタル コーポレーション | ウイルス複製の阻害 |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| PL201419B1 (pl) | 2002-12-04 | 2009-04-30 | Inst Biotechnologii I Antybiot | Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina |
| EP2986115A4 (en) * | 2013-02-06 | 2017-03-01 | Academia Sinica | Antimicrobial peptides derived from hepatitis b virus core protein arginine-rich domain |
-
2017
- 2017-05-25 AU AU2017270201A patent/AU2017270201A1/en not_active Abandoned
- 2017-05-25 WO PCT/US2017/034489 patent/WO2017205631A1/en not_active Ceased
- 2017-05-25 BR BR112018074478-6A patent/BR112018074478A2/pt not_active IP Right Cessation
- 2017-05-25 US US16/303,464 patent/US20190144510A1/en not_active Abandoned
- 2017-05-25 KR KR1020187035660A patent/KR102530478B1/ko active Active
- 2017-05-25 CN CN201780032261.3A patent/CN109641938A/zh active Pending
- 2017-05-25 SG SG11201809928VA patent/SG11201809928VA/en unknown
- 2017-05-25 MX MX2018014490A patent/MX2018014490A/es unknown
- 2017-05-25 EP EP17803588.7A patent/EP3464329A4/en active Pending
- 2017-05-25 CA CA3024873A patent/CA3024873A1/en not_active Abandoned
- 2017-05-25 JP JP2018561017A patent/JP7161263B6/ja active Active
- 2017-05-26 TW TW106117731A patent/TWI635095B/zh active
-
2018
- 2018-11-18 IL IL263086A patent/IL263086A/en unknown
- 2018-11-19 ZA ZA2018/07763A patent/ZA201807763B/en unknown
-
2020
- 2020-07-17 US US16/932,372 patent/US12084479B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201807763B (en) | 2020-10-28 |
| TWI635095B (zh) | 2018-09-11 |
| TW201808985A (zh) | 2018-03-16 |
| CA3024873A1 (en) | 2017-11-30 |
| US20210101939A1 (en) | 2021-04-08 |
| JP7161263B2 (ja) | 2022-10-26 |
| KR20190001954A (ko) | 2019-01-07 |
| SG11201809928VA (en) | 2018-12-28 |
| JP7161263B6 (ja) | 2023-03-20 |
| EP3464329A4 (en) | 2020-08-26 |
| JP2019523220A (ja) | 2019-08-22 |
| US12084479B2 (en) | 2024-09-10 |
| KR102530478B1 (ko) | 2023-05-10 |
| AU2017270201A1 (en) | 2018-11-29 |
| IL263086A (en) | 2018-12-31 |
| EP3464329A1 (en) | 2019-04-10 |
| WO2017205631A1 (en) | 2017-11-30 |
| US20190144510A1 (en) | 2019-05-16 |
| MX2018014490A (es) | 2019-06-24 |
| CN109641938A (zh) | 2019-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017025499A2 (pt) | benefícios da suplementação com n-acetil cisteína e glicina para melhorar os níveis de glutationa | |
| EP3328843A4 (en) | 1,3,4-OXADIAZOLSULFONAMID DERIVATIVE COMPOUNDS AS A HISTONDEACETYLASE INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| MX2018010983A (es) | Derivado de 3-desoxi y composiciones farmaceuticas del mismo. | |
| HRP20220531T1 (hr) | Varijabilni fragmenti antitijela koji se umeću i modificirane a1-a2 domene nkg2d liganda | |
| BR112016026773A2 (pt) | domínios variáveis de imunoglobulina aperfeiçoados | |
| BR112014017021A8 (pt) | inibidores de irak e usos dos mesmos | |
| EA201791903A1 (ru) | β-D-2'-ДЕЗОКСИ-2'-α-ФТОР-2'-β-C-ЗАМЕЩЕННЫЕ-2-МОДИФИЦИРОВАННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ HCV ЗАБОЛЕВАНИЙ | |
| BR112014012808A2 (pt) | proteína de fusão anticâncer | |
| BR112018009645A2 (pt) | composições e métodos para a expressão de vários polipeptídeos biologicamente ativos a partir de um único vetor para tratamento de condições cardíacas e outras patologias | |
| BR112017018022A2 (pt) | "compostos antivirais, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos | |
| BR112017016068A2 (pt) | composições para modulação de expressão de c9orf72 | |
| EA201691794A1 (ru) | Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa) | |
| BR112015022462A2 (pt) | inibidores de ido | |
| BR112016005270A2 (pt) | compostos de aza-piridona, composições farmacêuticas e seus usos | |
| BR112018072545A2 (pt) | inibidores da arginase e suas aplicações terapêuticas | |
| BR112017021970A2 (pt) | bioconjugados e usos dos mesmos | |
| BR112018074478A2 (pt) | peptídeo antimicrobiano modificado derivado de um domínio rico em arginina | |
| EA202090720A1 (ru) | ПРОИЗВОДНЫЕ GalNAc | |
| EP3619210A4 (en) | LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LMPTP) INHIBITORS AND ASSOCIATED USES | |
| EA201592184A1 (ru) | 4'-фтор-2'-метилзамещенные нуклеозидные производные | |
| BR112016026842A2 (pt) | preparação compreendendo fator viii e peptídeos de fator de von willebrand | |
| BR112017000246A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal | |
| BR112018013761A2 (pt) | compostos antiproliferativos e suas composições farmacêuticas e usos | |
| MX2017015189A (es) | Neutralizacion de moleculas de union anti-influenza y usos de las mismas. | |
| BR112018013246A2 (pt) | rótulo de peptídeo e proteína rotulada incluindo o mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2672 DE 22-03-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |